JWH 203 N-(4-hydroxypentyl) metabolite

Territorial Availability: Available through Bertin Technologies only in France

Technical Warning: Bertin Technologies restricts the sale of this product to licensed controlled substance laboratories and qualified academic research institutions. Please contact us for further details.

Special Advice: Please check regulation status before ordering; additionel fees can apply.

• Synonyms
  • 2-(2-chlorophenyl)-1-[1-(4-hydroxypentyl)-1H-indol-3-yl]-ethanone
• Correlated keywords
  • cannabinoids receptors JWHs 250 CB1 CB2 cannabimimetics forensics pains metabolites CBs JWH-250 JWH250 203 JWH203 JWH-203 metabolism serum urine phase I hydroxylated hydroxypentyl neurosciences forensics analgesics chemicals phenylacetylindole agonists synthetics central peripheral 13634 phenylacetyl naphthoyl rings aminoalkylindole potent binding binds activity physiological research applications analytical references standards
• Product Overview:
  JWH 203 (Item No. 9000736) is an analgesic chemical from the phenylacetylindole family that acts as a cannabinoid (CB) agonist with Ki values of 8.0 and 7.0 nM at the central (CB1) and peripheral (CB2) CB receptors, respectively.{17655} Similar to the related 2′-methoxy compound JWH 250 (Item No. 13634), JWH 203 has a phenylacetyl group in place of the naphthoyl ring used in most aminoalkylindole cannabinoid compounds. Compared to JWH 250, JWH 203 displays slightly more potent binding affinities for the CB1 and CB2 CB receptors (JWH 250 Kis = 11 and 33 nM, respectively).{17655} JWH 203 N-(4-hydroxypentyl) metabolite is expected to be a metabolite of JWH 203 that would be detectable both in serum and in urine. While similar hydroxylated phase I metabolites of synthetic CB retain activity, the physiological properties of this compound have yet to be determined.{20952,20953} This product is intended for research and forensic applications.